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Balance between excitation (E) and inhibition (I) is a key principle for neuronal network organization 
and information processing. Consistent with this notion, excitation-inhibition imbalances are 
considered a pathophysiological mechanism in many brain disorders including autism spectrum 
disorder (ASD). However, methods to measure E/I ratios in human brain networks are lacking. Here, we 
present a method to quantify a functional E/I ratio (fE/I) from neuronal oscillations, and validate it in 
healthy subjects and children with ASD. We define structural E/I ratio in an in silico neuronal network, 
investigate how it relates to power and long-range temporal correlations (LRTC) of the network’s 
activity, and use these relationships to design the fE/I algorithm. Application of this algorithm to the 
eeGs of healthy adults showed that fE/I is balanced at the population level and is decreased through 
GABAergic enforcement. In children with ASD, we observed larger fE/I variability and stronger LRTC 
compared to typically developing children (TDC). Interestingly, visual grading for EEG abnormalities 
that are thought to reflect E/I imbalances revealed elevated fE/I and LRTC in ASD children with normal 
EEG compared to TDC or ASD with abnormal EEG. We speculate that our approach will help understand 
physiological heterogeneity also in other brain disorders.
Excitatory (E) and inhibitory (I) systems are critical for regulating the flow of information in the brain. Without 
narrow control over the E/I ratio, runaway excitation or quiescence would occur, impeding adequate information 
processing1,2. In clinical terms, disruption of E/I balance has become a dominant theory on the pathogenesis of 
various neurodevelopmental disorders, and perhaps most explicitly in autism spectrum disorder (ASD)3–6. The 
nature, however, of implicated E/I imbalances on ASD is diverse, ranging from molecular changes to altered 
neuronal circuits3,7,8 and has been hypothesized to explain some of the variability in treatment responses7. E/I 
ratio may be regulated at the level of synaptic currents and network connectivity2,4,9,10 and both levels affect the 
dynamics of ongoing network activity11–16. Thus, it may be possible to derive a quantitative measure of E/I ratio 
from ongoing brain activity, e.g., as measured with electroencephalography (EEG). Such a measure would allow 
testing hypotheses about the functional role of E/I ratio8, could enable physiological stratification within neu-
rodevelopmental disorders and facilitate personalized application of E/I-modulating therapies3,7,17.
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The theory of critical brain dynamics links E/I balance to the scale-free statistical character of network activ-
ity18–25. Specifically, neuronal networks exhibit scale-free spatial and long-range temporal correlations of activ-
ity patterns when they operate near the critical point, poised between a low-activity sub-critical phase—which 
occurs when there is excessive net inhibition—and a relentlessly active super-critical phase associated with exces-
sive net excitation18,26. Of note, even though the spectral power of activity increases with increasing excitation 
it is not possible to infer the transition point where excitation and inhibition in the network are in balance from 
power analysis alone25. Hence, it is plausible that combining two properties of neuronal network activity—the 
spectral power and long-range temporal correlations—can lead to an estimate of E/I ratio. Here, we develop this 
idea using a computational model of neuronal network oscillations and test the algorithm using EEG datasets 
from healthy controls and children with ASD.
Results
Development of an algorithm to estimate E/I ratio from neuronal oscillations. To develop an 
algorithm for estimating E/I ratio, we used an extended version of the Critical Oscillations (CROS) in silico model 
of ongoing neuronal activity25 (Methods). It has been shown previously that the activity generated by the model 
reproduces the statistics of amplitude fluctuations of neuronal oscillations in humans27,28 and the spatial spread-
ing of activity in cortical slices23 when there is a certain balance between the number of excitatory and inhibitory 
connections in neuronal networks25. Therefore, we introduce here a definition of a network-level structural E/I 
ratio and use this parameter to control the activity in the model with the aim to develop a functional measure of 
excitation/inhibition ratio.
We define the network’s structural E/I ratio (sE/I) as the number of excitatory-to-excitatory synapses divided 
by the number of inhibitory-to-excitatory synapses. The assemblies in the CROS model produce activity across 
a wide range of frequencies and prominent oscillations in the 8–13 Hz range for most combinations of excitatory 
and inhibitory connectivity (Fig. 1d)25. Examining the spectral amplitude of these oscillations, we found a clear 
increase in amplitude with increasing sE/I (Fig. 1a,b,d,e). The temporal structure of the network oscillations also 
varied with changes in sE/I with notably larger temporal heterogeneity at an intermediate value of sE/I (Fig. 1b,c). 
To quantify this effect, we applied detrended fluctuation analysis (DFA) to the amplitude envelope of the alpha 
oscillations to obtain the DFA exponent, β, which is a measure of long-range temporal correlations (LRTC) and 
widely used as an index of critical oscillation dynamics21,27. DFA exponents significantly above 0.5 and below 1.0 
indicate LRTC of a power-law form. DFA of network signals from the CROS model indeed revealed significant 
LRTC (Fig. 1c,f). Importantly, these LRTC showed an inverse U-shaped relation with sE/I so that their scaling 
exponents peaked when excitation and inhibition were in a certain balance to one another (Fig. 1g).
The observed strong coupling in the CROS model between sE/I, oscillation amplitude, and LRTC suggests 
that it could be possible to derive a measure of network-level E/I from oscillatory activity. However, the sE/I 
modelling also showed that neither the amplitude nor LRTC alone are sufficient to determine whether a network 
operates in the inhibition- or excitation-dominated regime (Fig. 2a). Firstly, oscillation amplitude (i.e., the square 
root of the power) exhibited an approximately linear relationship with sE/I (Fig. 1e) and, thus, cannot define a 
reference point for when the E/I structure is balanced. Secondly, the inverse U-shaped relationship between sE/I 
and LRTC (Fig. 1g) implies that different sE/I ratios can lead to the same LRTC. To overcome these limitations, 
we hypothesize that in spite of a fixed structural connectivity in a network there will be fluctuations in oscillation 
amplitude and LRTC that relate to the sE/I. This is plausible because networks exhibiting LRTC, show periods 
of high and low amplitude (Fig. 1c). Importantly, if these fluctuations in oscillation amplitude and LRTC follow 
the relationships seen in Fig. 1e,g, then it also follows that a functional form of E/I ratio (fE/I) can be estimated 
from the covariance of amplitude and LRTC within a signal and that this fE/I should be related to sE/I. This would 
predict a positive relationship between amplitude and LRTC for sub-critical networks, and a negative relationship 
for super-critical networks (Fig. 2a). Importantly, while fE/I is expected to correlate with sE/I, the structural and 
functional expressions of E/I balance are not necessarily identical. In analogy, functional connectivity derived 
from BOLD-signal fluctuations measured with fMRI merely shows moderate correlation with structural connec-
tivity in large-scale brain networks as measured with diffusion tension imaging29. In other words, structure affects 
function but they are not the same.
One method to calculate the covariance of amplitude and LRTC would be to split the signal into segments, 
calculate these measures for each segment, and then correlate them. However, due to the length of data required 
for each segment to get a reliable estimate of the DFA exponent this would require recordings longer than 10 
minutes21. Moreover, it may be that E/I ratio as expressed in activity is changing on time scales of seconds rather 
than tens of seconds. Thus, to develop a sensitive functional E/I measure, we seek a method that estimates LRTC 
on short time-scales. To this end, we use the fluctuation function from the detrended fluctuation analysis, F(t), 
which is a candidate estimator for the DFA exponent on short-time scales. For scale-free signals, an increase in 
LRTC will lead to a corresponding increase in the fluctuation function on all time-scales. However, correlating 
the DFA exponent with the mean fluctuation, <F(t)>, in a certain window size (Fig. 2b), shows it to be a poor 
estimator of DFA exponents. Here, both measures are obtained using the entire signal. This is because the fluc-
tuation function is influenced by both the auto-correlations and the amplitude of the signal. This is illustrated in 
Fig. 2c, where doubling the magnitude of a signal, does not alter the LRTC within the signal, but does double the 
mean fluctuation for each window size. Therefore, for the fluctuation function to be a good estimator of the DFA 
exponent, it is necessary to remove the influence of amplitude on the fluctuation function by calculating the nor-
malized fluctuation function nF(t). The mean normalized fluctuation function (<nF(t)>) is a reliable estimator 
of the DFA exponent of that signal (Fig. 2d) and can be calculated on time-scales as short as a few seconds. nF(t) 
does not require calculation on many different time scales in order to estimate DFA exponent as by assuming a 
linear (scale-free) relationship there is a one-to-one mapping between nF(t) and DFA exponent (Fig. 2d).
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Each analytical step from oscillations to the detrended amplitude-normalized signal profile that is necessary 
for calculating the nF(t) is illustrated for one example network in Fig. 2e: The signal is band-pass filtered (i), the 
amplitude envelope extracted (ii), the signal profile, S, of the amplitude envelope, A, is calculated as the cumula-
tive sum of the demeaned amplitude envelope (iii):






and split into windows of a certain size (e.g., 5 seconds) as in the DFA calculation21,30. Importantly, as an addi-
tional step (iv), each of these signal-profile windows is divided by the mean of the amplitude envelope for that 
window calculated during step (ii). These amplitude-normalized windows are then detrended (v) and, subse-
quently, we calculate the normalized fluctuation function nF(t) for each window as the standard deviation of the 
amplitude-normalized signal profile (vi). By calculating nF(t) as a proxy of LRTC on short time scales and ampli-
tude on overlapping windows of 5 seconds, it is possible to test whether the hypothesized relationship between 
LRTC and amplitude holds for networks with different sE/I (Fig. 2a). These associations were indeed observed in 
networks that were representative of inhibition-dominated, balanced or excitation-dominated regimes (Fig. 2f). 
Thus, we can define a functional excitation-inhibition ratio as:




























































































































Figure 1. Amplitude and long-range temporal correlations of oscillations strongly depend on structural E/I. 
(a) Number of connections between neuron types for five different networks with increasing structural E/I. (b) 
Network activity filtered in the 8–13 Hz band shows increasing oscillation amplitude with increasing structural 
E/I. (c) Z-scored activity of (b) shows differing temporal structure of oscillation amplitude for balanced and 
unbalanced networks. (d) Power spectrum for networks in (b). (e) Spectral amplitude in the 8–13 Hz band 
increases with structural E/I. Running mean amplitude values of 300 networks (thick line) +/− 1 standard 
deviation (thin lines). (f) Detrended fluctuation analysis (DFA) applied to the amplitude envelope of 8–13 Hz 
filtered signals in b shows increasing scaling exponents for balanced (green) compared to unbalanced networks 
(blue, red). (g) DFA exponents show an inverse u-shaped relationship with structural E/I.
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Figure 2. Joint fluctuations in the amplitude and scaling of oscillations enable estimation of the excitation-
inhibition ratio of a neuronal network. (a) Similar LRTC (quantified by DFA) can be produced by two networks 
with different sE/I. In the blue area, increasing LRTC correspond to increasing amplitude of oscillations, in the 
orange area decreasing LRTC correspond to increasing amplitude of oscillations. (b) The mean fluctuation 
(log10 < F(t)>) for a window size of 5 seconds is a poor predictor of the DFA exponent. Each dot represents one 
network realization simulated for 1000 seconds, and the mean fluctuation and the DFA exponent are derived 
from the entire signal. (c) Mean fluctuation values (log10 < F(t)>) for a window-size scale proportionally with 
signal magnitude and with LRTC. Therefore, if we normalize the amplitude of the signal for a certain window 
size then the fluctuation in that window size would be an estimate of the DFA exponent. (d) After normalizing 
the signal profile windows, the DFA exponents can be estimated by their mean fluctuation, log10 < nF(t)> 
(shown for a window size of 5 seconds). Each value represents the average of 20 networks for each combination 
of excitatory and inhibitory connectivity parameters. (e) Method to calculate fE/I. (i) The model signal filtered 
in the alpha range (dark thin green), and the same signal with double the magnitude (thick light green). (ii) 
Amplitude envelope of the two signals. (iii) Signal-profile deviations are greater for the larger-magnitude signal 
(light green). (iv) Dividing each window by its original mean amplitude, removes any effect of original 
magnitude on the signal profile. (v) Subtract the linear trend. (vi) Calculate the standard deviation for each 
window to get the normalized fluctuation function, nF(t). (vii) fE/I is calculated by correlating the mean 
windowed amplitudes calculated from ii and the windowed nF(t) calculated in (vi). (f) Correlation between 
windowed values for nF(t) and amplitude is used to create the estimate of fE/I, shown for three example 
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Where rW W,amp nF t( ) is the Pearson correlation between the set of windowed detrended amplitude-normalized 
signal profiles, wnF(t), and the set of windowed amplitude values, wamp. Inhibition-dominated networks will hence 
be assigned fE/I below 1, excitation-dominated networks fE/I greater than 1, and critical networks will have fE/I 
= 1. We use a DFA > 0.6 inclusion criterion for signals before computing the fE/I because networks without LRTC 
will not show a co-variation of amplitude and the fluctuation function (see the gray zones in Fig. 2a); however, 
this should not be a strongly limiting factor of the method given the robustness of LRTC in human resting-state 
oscillations31. Corroborating this observation with the simulated data, we found that the fE/I correctly assigned 
networks to be excitation or inhibition dominated (Fig. 2g,h), and that sE/I and fE/I were strongly correlated 
(r(60) = 0.83, p < 10−16, Fig. 2i).
Structural E/I could be defined also in other ways; however, the method and subsequent results reported here 
are not dependent on the exact definition, e.g., the correlation between sE/I and fE/I does not change notably with 
the exact definition of sE/I (if sE/I = (E→E)/(E→I + I→ E + I→I): r(60) = 0.82, p < 10−15. sE/I = (E→E + I→I)/
(E→I + I→E): r(60) = 0.82, p < 10−15). What matters is that for a certain structural level of excitation and inhi-
bition—as indicated by the highlighted squares on the diagonal in Fig. 2g—neuronal network activity exhibits a 
specific covariance between the level of activity and its temporal dynamics (Fig. 2h), which makes it possible to 
calculate a functional form of E/I directly from ongoing oscillations in the network activity. Importantly, while 
our model produces activity with spectra that are similar to eyes-closed rest EEG recordings with a dominant 
peak in the alpha-frequency band (Fig. 1d), we found that applying the analysis to other classical frequency bands, 
we obtained similar results (Pearson (sE/I, fE/I) Delta: r(84) = 0.81, p < 10−19; Theta: r(55) = 0.80, p < 10−13; Beta: 
r(53) = 0.81, p < 10−13; Gamma: r(45) = 0.81, p < 10−11). These results suggest that the method does not require 
prominent peaks in the power spectrum but merely that the neuronal activity emerges from a network that is near 
the critical point (as defined by DFA > 0.6).
Equating sE/I to the ratio of synapses of a certain type provides a straightforward manner for controlling E/I 
balance in the CROS networks. However, when defined in this way, sE/I neglects other properties of a neuronal 
network that can affect activity propagation and which, in turn, could influence fE/I. For example, networks 
with similar structural E/I ratio could have topologies that differ in how they facilitate activity propagation and, 
thus, the functional expression of E/I balance. To investigate this, we related fE/I directly to a measure of activity 
propagation that is known to reflect E/I balance, namely neuronal avalanches23. Networks with balanced E/I and 
critical dynamics exhibit a power-law distribution of avalanche sizes (Supplementary Fig. S1a). In sub-critical 
networks, the strong inhibition prevents large avalanches from occurring and, thus, the avalanche-size distri-
bution is below that of a critical network. In super-critical networks, the excess excitation often prolongs the 
avalanches, leading to an avalanche-size distribution with values above that of a critical network (Supplementary 
Fig. S1a). To quantify the proximity of the measured avalanche-size distribution to a power law, we used the 
κ index (Supplementary Fig. S1b, Supplementary Methods)32. Critical dynamics of avalanches (κ = 1.0) were 
indeed found for an intermediate value of sE/I (Supplementary Fig. S1c). However, we found that networks with 
similar sE/I exhibit a wide range of κ values (Supplementary Fig. S1c), confirming that there are factors not 
captured in our measure of sE/I that affect activity propagation in the form of neuronal avalanches. Importantly, 
when we correlated fE/I to κ we found a much stronger relationship than that of fE/I with sE/I (Pearson (κ, fE/I) 
r(60) = 0.96, p < 10−33, Fig. 2j) showing that fE/I accurately distinguishes between the inhibition-dominated 
subcritical regime and the excitation-dominated supercritical regime. Thus, fE/I is better seen as an index of the 
balance between excitatory and inhibitory activity that emerges out of the network structure, rather than a direct 
measure of the E/I ratio of the network structure itself. This suggests that fE/I could be used to infer the functional 
E/I ratio from the network dynamics regardless of the mechanisms affecting these dynamics.
Functional E/I ratio in humans is balanced in the eyes-closed rest state and sensitive to syn-
aptic modulation. Our model results suggest that if mass-neuronal activity in the human brain is poised 
close to the critical state during rest18,24,33,34, then fE/I should be close to one. To corroborate this prediction, we 
recorded EEG during eyes-closed rest in 176 healthy adults and calculated the fE/I values in the alpha band. At 
the group level, the method proved applicable with the DFA-threshold criterion of >0.6 met by 84% of the signals 
and revealed that fE/I was highest in frontal, parietal and occipital regions (Fig. 3a). Interestingly, averaging fE/I 
across all electrodes to get a “whole-brain estimate” of functional E/I ratio revealed that the operating point of the 
activity varied across subjects between sub- and super-critical regimes with a mean fE/I close to one (0.99 ± 0.17, 
mean ± SD). Together, this indicates that a balanced E/I ratio is indeed typical for whole-brain dynamics at rest 
in non-clinical populations.
Next, we hypothesized that not only structural connectivity would influence fE/I (Fig. 2g-i), but also changes 
to synaptic functioning9. To investigate this, we extended the model so that the decay constants of excitatory and 
inhibitory inputs could be changed independently. Simulations were run for the same networks used in the simu-
lations for Fig. 1, but now using three different inhibitory input decay constants (10, 11, and 12 ms) and compared 
networks with low (1.82, left), medium (2.05, middle), and high (2.25, right) sE/I, respectively. (g) The sE/I index 
is shown in color scale for the phase space of inhibitory and excitatory connectivities with E-I combinations 
producing oscillations with DFA > 0.6 indicated with black squares. (h) For networks close to the critical state, 
fE/I correctly assigns their activity to be either inhibition dominated (blue), excitation dominated (red) or in 
balance (white squares). For strongly inhibition- or excitation-dominated networks, DFA is not significant and 
the presented method is not applicable (gray regions, where DFA ≤ 0.6). (i) fE/I is associated strongly with sE/I 
(calculated for networks between sE/I = 1–3 that pass the inclusion criterion of DFA > 0.6). (j) fE/I exhibits 
stronger correlation with κ than with sE/I.
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to that of the baseline networks with 9 ms decay constant (see Methods) to show how an increase in inhibitory 
input decay alters network dynamics. The fE/I showed a significant decrease compared to baseline (Fig. 3b) for 
all decay-time constants (9 ms: 1.35 ± 0.04, mean ± SEM of fE/I for 42 combinations of excitatory-inhibitory 
connectivity; 10 ms: 1.05 ± 0.06, p < 10−6; 11 ms 0.76 ± 0.05, p < 10−7; 12 ms: 0.61 ± 0.03, p < 10−7; Wilcoxon 
signed-rank test, Bonferroni corrected for 3 comparisons). Thus, our measure of fE/I is sensitive not only to 
structural but also to synaptic influences on excitation-inhibition balance in the model.
To confirm that our method can detect changes in E/I ratio through pharmacological manipulation, we 
conducted a challenge in healthy adults comparing placebo (n = 14) to zolpidem (n = 18, 10 mg orally)—an 
E/I-modulating agent that enhances GABAergic synaptic inhibition by increasing the decay-time constant of 
GABAA receptor-mediated postsynaptic currents35. In accordance with zolpidem’s pharmaco-kinetic proper-
ties36, and corroborating the model simulations (Fig. 3b), we observed a significant reduction of fE/I in zolpidem 
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Figure 3. fE/I is balanced in healthy populations and can detect pharmacologically induced shifts in excitation/
inhibition ratio. (a) Grand average fE/I topography during eyes-closed rest (n = 176). (b) Increasing inhibitory 
decay rate in the model is associated with decreasing fE/I. (c) Eighteen subjects taking zolpidem, which 
increases inhibitory input decay constant, show a significant decrease in fE/I and a return to baseline values 
after 4–6 hours both relative to baseline (blue asterisks) and relative to the placebo control (black asterisks). 
The bipolar Oz-Pz electrode position measured is indicated on the inset. Bonferroni-corrected P-values are 
indicated as * <0.05. (d) Filtered signal (left column) and fE/I (right column) shown for a single subject 
(zolpidem condition) at four time points.
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compared to placebo, between 30 min and 2 h after the administration (bipolar Oz-Pz electrode, Wilcoxon 
rank-sum test, Bonferroni corrected for 4 comparisons, zolpidem vs Placebo, 0–0.5 h: p = 0.8; 0.5–2 h: p = 0.004; 
2–4 h: p = 0.02; 4–6 h: p = 0.25) (Fig. 3c). The zolpidem group also showed significant decreases compared to the 
baseline block (0–30 min), between 30 min and 4 h after the administration (Wilcoxon signed-rank test, mean 
± SEM, Bonferroni corrected for 3 comparisons, 0–0.5 hours: 1.16 ± 0.06; 0.5–2 hours: 0.92 ± 0.05, p = 0.007; 
2–4 hours: 0.89 ± 0.05, p = 0.003; 4–6 hours: 1.10 ± 0.08, p = 0.62). Note that the high baseline fE/I values relate to 
the Oz-Pz bipolar electrode measured during the pharmacological intervention and this is the scalp region with 
the highest fE/I values (cf., Fig. 3a). Looking at a single subject (Fig. 3d), we can see how observable reductions 
in amplitude and changes in amplitude dynamics after administration of zolpidem are mirrored by changes in 
the relationship between windowed amplitude and nF(t). Together, these findings suggest applicability of the fE/I 
method for clinical purposes and treatment-effect monitoring.
Shifts in E/I ratio may also occur between brain states under the action of neuromodulatory systems 37,38, in a 
manner analogous to the zolpidem pharmacological manipulation. While the eyes-closed resting state has been 
associated with critical balance, neuronal dynamics shift to a subcritical state during eyes-open rest 39,40, which is 
associated with a lower E/I ratio25. We compared the whole-brain average fE/I values in the alpha band for the 176 
EEG eyes-closed rest recordings with a group of 73 healthy adults that underwent eyes-open rest EEG recordings. 
We found fE/I to be decreased during eyes-open rest compared to eyes-closed rest (Wilcoxon rank-sum test, 
mean ± SEM, eyes-closed rest: 0.99 ± 0.01, eyes-open rest: 0.81 ± 0.02, p < 10−14, Supplementary Fig. S2). Thus, 
fE/I can also track changes in E/I ratio between cortical states.
ASD is characterized by alterations in critical brain dynamics. To test the hypothesis that E/I imbal-
ances characterize ASD 4,41, we applied the algorithm to eyes-closed rest EEG recordings in non-medicated chil-
dren with ASD (ASDall; n = 100, 7–15 years) and age-matched typically developing children (TDC; n = 29) 
(Table 1 and Supplementary Table S1). The children with ASD had lower total IQ (p < 0.001) than TDC (Table 1). 
As with the CROS-model activity, we analyzed relative power (RP), LRTC, and fE/I in the alpha band of the EEGs. 
The topography of RP showed the characteristic occipito-parietal distribution of eyes-closed rest recordings 
both in TDC and ASD without between-group differences in mean or variance of whole-brain averages (Fig. 4a; 
Wilcoxon rank-sum test, mean ± SEM; RPASDall = 26.8 ± 1.1% and RPTDC = 27.2 ± 2.1% p = 0.84; Levene’s test 
of variance: p = 0.82). The scalp distribution of LRTC quantified by DFA was also similar between TDC and 
ASD, but whole-brain average and variability were both larger in ASD (Fig. 4b; βASDall = 0.70 ± .01, and βTDC = 
0.65 ± 0.01 p = 0.01; Levene’s test: p = 0.001). The scalp topography of fE/I of alpha oscillations showed similar 
distributions in ASDall and TDC. A pronounced variability of fE/I was evident in ASDall (Fig. 4c; Levene’s test: p 
= 0.04), characterized by more extreme values of fE/I in both directions away from the balance point although 
between-group differences of whole-brain average fE/I were not significant (Fig. 4c; fE/IASDall = 1.03 ± 0.02 and 
fE/ITDC = 1.01 ± 0.02, p = 0.65).
Albeit IQ may be considered part of the disorder rather than a confounding factor42, we performed an 
ANCOVA test to investigate whether the above findings could be explained by the differences in IQ. This analysis 
did not change the outcomes on whole-brain averaged RP (F(1,124) = 0.28, p = 0.59, partial η2 =0.002), nor for 
fE/I (F(1,124) = 0.19, p = 0.66, partial η2 = 0.002); however, the difference in means for LRTC is merely a trend 
after adjusting for TIQ scores (F(1,124) = 3.2, p = 0.07, partial η2 = 0.026). Together, our findings suggest that 
larger variability of LRTC and fE/I contribute to the physiological heterogeneity of ASD.
ASD without visual EEG abnormalities show elevated fE/I. Visual EEG abnormalities are common 
in ASD and have been proposed to indicate aberrant neuronal excitability and influence network-level E/I5,6,43. To 
test this hypothesis, we performed qualitative EEG inspection for abnormalities and investigated their association 
to relative power, LRTC, and fE/I. For a comprehensive analysis of visual EEG patterns, we used the EEG classi-
fication of Luders & Noachtar44. Consistent with previous studies45,46, we identified EEG abnormalities in 46% of 
ASD cases (ASDabn, n = 46) ranging from slowing of activity (n = 38) to epileptiform abnormalities (n = 8). Of 
note, none of the subjects with ASD had suffered from seizures nor had received a diagnosis of epilepsy. No visual 
abnormalities were found in any of the TDC subjects.
TDC ASD t (df)/W, z p-value
n 29 100 — —
Males/female 14/15 73/27 — —
Age 
(mean ± SEM) 10.3 ± 0.28 10.5 ± 0.23 −0.64 (67) 0.524
ADOS 
(mean ± SEM) N/A 9.35 ± 0.38  —  —
TIQ 
(mean ± SEM) 120.6 ± 2.63 101.4 ± 2.08 5.705 (64) <0.001
SRS-T 
(mean ± SEM) 43 ± 0.73 75.26 ± 1.02 406, −8.06 <0.001
Table 1. Clinical characteristics of children with ASD and typically developing children. Mean values and 
comparison’s statistics (t-test for parametric data (t, df) and Wilcoxon rank-sum test for non-parametric data 
(W, z). Demographics and EEG mean biomarker values per subject included in our study can be found on 
Supplementary Table S1. ADOS (Autism Diagnostic Observation Scale); TIQ (Total Intelligence Quotient); 
SRS-T (Social Responsiveness Scale, (T-scores). N/A (not applicable).
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The ASD subsample with an abnormal EEG had markedly different quantitative EEG compared to the ASD 
with a normal EEG (ASDnl; n = 54) across the scalp as reflected in lower relative power (Fig. 5a; whole-brain aver-
age RPASDabn = 19.8 ± 1.2% vs. RPASDnl = 32.8 ± 1.4%, p < 0.00001), weaker LRTC (Fig. 5b; whole-brain average 
βASDabn = 0.68 ± 0.01 vs. βASDnl = 0.73 ± 0.01, p = 0.006), and lower fE/I (Fig. 5c; whole-brain average fE/IASDabn = 
0.97 ± 0.01 vs. fE/IASDnl = 1.08 ± 0.02 and, p = 0.0003). ASD with abnormalities also differed from TDC in terms 
of lower relative power (Fig. 5d; RPTDC = 27.2 ± 2.1%, p = 0.01); however, neither LRTC or fE/I reached statistical 
significance (Fig. 5e; βTDC = 0.66 ± 0.01, p = 0.39; Fig. 5f; fE/ITDC = 1.01 ± 0.02, p = 0.11). Interestingly, in spite 
of having no visual EEG abnormalities, we found pronounced differences for ASDnl compared to TDC both in 
terms of higher relative power (Fig. 5g; RPASDnl = 32.8 ± 1.4% vs. RPTDC = 27.2 ± 2.1%, p = 0.009), stronger LRTC 
(Fig. 5h; βASDnl = 0.73 ± 0.01 vs. βTDC = 0.66 ± 0.01, p = 0.00035) and higher fE/I (Fig. 5i; fE/IASDnl = 1.08 ± 0.02 
vs. fE/ITDC = 1.01 ± 0.02, p = 0.03). Taken together, our data show that dissecting the ASD cohort into the pres-
ence or absence of EEG abnormalities is essential for revealing strong effects both in the classical relative power 
and in biomarkers rooted in criticality theory (Figs. 4 and 5).
Subjects with higher SRS scores tend to have higher fE/I. To determine if the level of core clinical 
symptoms in ASD had an effect on the fE/I estimates, we divided the ASDall group into high and low Social 
Responsiveness Scale (SRS-t) t-scores using a median split and compared the groups. We found that the ASD 
group with high SRS scores had a trend towards higher fE/I than the ones with low SRS (Supplementary Fig. S3, 
Wilcoxon rank-sum test, mean ± SEM; fE/I ASDSRS_low = 1.0 ± 0.018, fE/I ASDSRS_high = 1.06 ± 0.022, p = 0.08).
Figure 4. Alpha oscillations in ASD are characterized by strong LRTC and large variability in fE/I. Grand-
average topographies for the EEG biomarkers are shown for TDC (first column), ASD (second column), and 
for ASD-minus-TDC (third column). (a) Relative power (RP) showed the characteristic occipito-parietal 
distribution both in TDC and ASD. (b) Whole-brain average and variability of LRTC quantified by the DFA 
exponent were both larger in ASD compared to TDC. (c) A pronounced variability of whole-brain fE/I was 
evident in ASD. White circles on the topographies represent significant channels (i.e., p-value < 0.05, using 
Wilcoxon rank-sum test and FDR correction). The fourth column shows individual-subject values, boxplots, 
and mean and SEM for TDC (blue circles) and ASD (red squares). Comparisons represented in boxplots were 
based on the average value of the EEG biomarkers across all 64 electrodes, each data point represents one 
subject (whole-head average; p-values are from Wilcoxon rank-sum test (mean)/Levene’s test (variability).
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Discussion
We have introduced a measure of functional E/I ratio (fE/I) from network activity that is sensitive to both 
changes in synaptic functioning and network connectivity and which is applicable to non-invasive human EEG 
recordings3,8. We validated the method in silico, and applied it to human EEG to find that a near-critical and 
E/I-balanced regime is typical for human eyes-closed resting-state brain activity in the alpha band19,27,33. In addi-
tion, we showed that pharmacological enhancement of GABAA receptor-mediated inhibition lowered fE/I as 
predicted. Finally, we found evidence to support the notion of E/I imbalances in ASD in that the variance in LRTC 
and fE/I is higher compared to TDC. Importantly, whereas children with visual abnormalities in the EEG merely 
had lower relative power compared to the TDC, the children without epileptiform or other visual changes showed 
elevated values of relative power, LRTC and fE/I.
In spite of the comprehensive literature on E/I balance3–6,11–16, there is no consensus on how to define or 
measure E/I ratio, neither functionally or structurally. The design of our measure of fE/I was guided by the the-
ory of critical brain dynamics, which is rooted in the physics concept of critical phase transitions23,47,48. This 
choice was motivated by the extensive evidence that brain activity at many levels of neuronal organization exhib-
its near-critical dynamics and that this requires balance between excitatory and inhibitory forces14,23,49,50. These 
forces can be structural in terms of neuronal connectivity or functional in terms of the kinetics of synaptic cur-
rents51, and the fE/I was indeed able to track changes in either of these parameters. Interestingly, albeit fE/I corre-
lated strongly with any of our definitions of structural E/I ratio (r > 0.8), the correlation with the Kappa measure 
of neuronal avalanches was even stronger (r > 0.94). Thus, fE/I is better seen as an index of the emergent balance 
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Figure 5. ASD without visual EEG abnormalities show strong LRTC and elevated fE/I. Compared to the 
children with ASD and a normal EEG (ASDnl), subjects with EEG abnormalities (ASDabn) had lower relative 
power in the alpha band (a), weaker LRTC (b) and lower fE/I (c). Compared to TDC, ASDabn had lower RP 
(d), but no significant difference in LRTC (e) or fE/I (f). In contrast, ASD subjects without any visible EEG 
abnormalities (ASDnl) showed higher RP than TDC (g), stronger LRTC (h) and higher fE/I (i). Grand-average 
topographies are shown for the cohort difference of the indicated comparisons (labels on top). The reported 
p-values are based on the Wilcoxon rank-sum test. White circles on the topographies represent significant 
channels as in Fig. 4. Comparisons at the left of the topographies were based on the average value of the EEG 
biomarkers across all 64 electrodes, each data point represents one subject (whole-head average, Wilcoxon 
rank-sum test).
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of the E/I ratio of the network structure itself. This suggests that fE/I could be used to infer the functional E/I ratio 
from the network dynamics regardless of the mechanisms affecting these dynamics.
Neuronal avalanches offer another method for estimating the E/I based on criticality theory23. One advantage 
our fE/I measure has over neuronal avalanches is that it allows an estimate at the single-electrode level, whereas 
neuronal avalanches assign one E/I level to all or to a pre-defined cluster of sensors or regions of interest when 
applied to multi-channel data24,34. Moreover, because the brain is not in one “state” as a homogeneous system but 
is composed of interacting networks that may each have their own level of criticality at any given time52 the appli-
cability of avalanche-based E/I estimation is questionable when dependent on sensors that span multiple brain 
regions. This is supported by the clear topographical distributions of fE/I seen both in the adult and the children 
cohorts (Figs. 3a, 4c). The scaling exponent of broadband 1/f signals has also been proposed to estimate changes 
in E/I balance16. Through computational and electrophysiological evidence they show that increasing inhibition 
induces steeper power spectra. One drawback of this method is that similar to measures of excitability such as 
alpha power (Fig. 2a), it does not provide an absolute value that corresponds to balanced E/I, or the critical point, 
and comparing 1/f slopes of the same area recorded with different modalities (EEG & MEG) suggests that this 
would be difficult to achieve53. This may reduce its usefulness as it does not allow hypotheses of function related to 
the critical point to be tested (e.g., increased dynamic range, information transmission, information capacity)32.
Non-invasive estimates of E/I have also been proposed using magnetic resonance spectroscopy (MRS) and 
stimulation methods such as paired-pulse transcranial magnetic stimulation (TMS). MRS can measure the levels 
of excitatory (glutamate) and inhibitory (GABA) neurotransmitters in a region54,55; however, it is not known how 
these concentrations relate to the power or dynamics of oscillations as investigated in our CROS model and in 
the human EEG data. Previous attempts to relate GABA levels with features of M/EEG have shown inconsistent 
results56,57, and so future studies will be necessary to investigate the relationship of MRS to fE/I. Paired-pulse 
TMS has also been used to look at intracortical facilitation and inhibition, i.e., measuring the excitability of an 
area. Previous studies have shown a relationship between variability of motor-evoked potential response and the 
variability or amplitude of alpha oscillation amplitude58,59, suggesting that there could be a relationship between 
fE/I and paired-pulse TMS, which should be investigated.
We restricted the current analysis to alpha-band oscillations but show that fE/I values in the CROS model were 
similar across frequency bands, which we explain by the oscillations at all frequencies being generated in the same 
in silico network. In the human brain, however, different circuits and network mechanisms may underlie oscil-
lations at different frequencies and, consequently, the fE/I could probe E/I balance specific to the microcircuits 
producing different oscillations. Alpha oscillations are known to become strongly suppressed by eye opening27. 
Indeed, we found lower fE/I during eyes-open rest compared to eyes-closed rest. This is consistent with previous 
studies, showing a shift towards subcritical neuronal dynamics in the eyes-open rest condition39. In fact, subcrit-
ical dynamics as observed during eyes-open rest may be beneficial during tasks60, especially for tasks that require 
focused attention49,61,62. Future studies may use fE/I to further investigate how performance in cognitive tasks 
relate to critical brain dynamics and E/I regulation34,63.
LRTC in critical brain dynamics are expected to reflect network stability and, therefore, LRTC in addition 
to fE/I may constitute a physiological biomarker of network dysfunction in ASD1,48. The development of the 
fE/I measure was needed as quantification of LRTC alone is insufficient to estimate how network E/I balance is 
altered (Fig. 2a). Using the novel algorithm, we found that both LRTC and fE/I variability was larger in ASD than 
in TDC. This seems to confirm experimental studies implicating both decreased, normal, or increased E/I ratios 
in ASD3,4,6,8. The original hypothesis of ASD as a disorder of elevated E/I was predominantly based upon the fre-
quent concurrence of epilepsy and epileptiform changes45,64. We found that the ASD cohort without any visible 
EEG abnormalities displayed elevated LRTC and fE/I over multiple scalp regions versus the control sample. This 
finding was further supported by the within ASD sample comparison (ASDnl vs. ASDabn) where the group with 
EEG abnormalities showed lower power, LRTC and fE/I.
We can thus far only speculate why seemingly inhibition-dominated networks may be associated with dif-
ferent types of EEG abnormalities. For instance, background slowing of activity is considered a sign of neurode-
velopmental delay or perinatal insults44,65,66. Intermittent slowing can indicate epileptiform changes in specific 
circumstances (e.g., cortical malformations or temporal lobe epilepsy)44,66–69 or an expression of protective mech-
anisms against epileptogenicity70. Whether EEG abnormalities interfere with information processing and whether 
they merit (anti-epileptic) treatment is debated46,71–73. So far, ASD trials have predominantly focused on agents 
that enforce inhibition or reduce excitation6. Indeed, some of these agents have been suggested to be effective in 
subsets of patients6,17 and our proposed method may be tested as stratification biomarkers to increase applicabil-
ity. A final aspect for future studies is whether the level of clinical impairment is also reflected in the characteris-
tics of these biomarkers. Our findings may point to a relation between more core symptom severity and elevated 
fE/I but investigation in larger samples is first needed.
In conclusion, we propose that parallel quantification of the critical brain dynamics indices of power, LRTC 
and fE/I may provide a novel theory-based framework to advance understanding of physiological heterogeneity 
of ASD and related disorders.
Methods
Computational model to estimate the excitation-inhibition ratio. CRitical OScillations (CROS) 
model. The CROS model is an in silico model that was created by Poil et al. (2012) with the aim of having a spik-
ing neuronal network that produced oscillatory activity with long-range temporal correlations in the oscillation 
amplitude. In this paper, we use an extended version of this model with optimized parameters to investigate the 
dependence of neuronal network activation patterns on structural connectivity and synaptic parameters. CROS 
models a network of 75% excitatory and 25% inhibitory integrate-and-fire neurons arranged in a 50 × 50 open 
grid25. Networks differ in their two connectivity parameters, CE and CI, which are the percentage of other neurons 
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within a local range (a square with width = 7 neurons centered on the presynaptic neuron) that each excitatory 
and each inhibitory neuron connects to, respectively. Connectivity parameters were set between 25–100% at 5% 
intervals, and 20 different networks were created for each combination of excitatory and inhibitory connectivity 
– CE and CI. For a full description of the model see Supplementary Methods.
Detrended fluctuation analysis of long-range temporal correlations. The detrended fluctuation analysis (DFA) was 
used to analyze the scale-free decay of temporal (auto)correlations in the amplitude modulation of neuronal oscilla-
tions, also known as long-range temporal correlations (LRTC)30. The DFA exponent, β, is the slope of the fluctuation 
function shown, e.g., in Fig. 1f. DFA exponents in the interval of 0.5 to 1.0 indicate scale-free temporal correlations, 
whereas an exponent of 0.5 characterizes an uncorrelated signal. The analytical steps to quantify LRTC using DFA 
have been explained in detail previously 21,27 and are briefly explained in Supplementary Methods.
Estimation of excitation/inhibition ratio (fE/I). For a full explanation of the rationale behind the algorithm to 
estimate excitation/inhibition ratio, we refer to the Results section because it is a new method. Here, we merely 
detail the sequence of analytical steps. To test the relationship between the amplitude and LRTC of the amplitude 
envelope of an oscillatory signal, it is necessary to have a measure of LRTC on short time-scales that is unbiased 
by the amplitude of the signal. To this end, we introduce an amplitude-normalized fluctuation function, nF(t), 
for a signal that is calculated as follows (Fig. 2d): The signal is band-pass filtered (i), the amplitude envelope 








and split into windows of a certain size (e.g., 5 seconds) in exactly the same way as during the DFA calcula-
tion21,30. Importantly, as an additional step (iv), each of these signal-profile windows is divided by the mean of the 
amplitude envelope for that window calculated during step (ii). These amplitude-normalized windows are then 
detrended (v) and, subsequently, we calculate the normalized fluctuation function for each window as the stand-
ard deviation of the amplitude-normalized signal profile (vi). To calculate the functional excitation/inhibition 
ratio, fE/I, perform a Pearson correlation between the amplitude and the normalized fluctuation function for the 
set of windows W (vii). fE/I is then defined as:
= −fE I r/ 1 (2)W W,amp nF t( )
All of the signal-processing steps (i)-(vii), and an illustration of how they affect the signal, are shown in Fig. 2e. 
Sub-critical networks will have an fE/I < 1, super-critical networks fE/I > 1, and critical networks will have fE/I = 
1. We used a DFA > 0.6 inclusion criterion for networks or channels before computing the fE/I because networks 
without LRTC will not show a co-variation of amplitude and the fluctuation function (Fig. 2a). For our analyses, 
fE/I was calculated for windows of 5 seconds with 80% overlap.
Validation and clinical application of fE/I method. Participants and EEG recordings. Ethical approval 
was obtained from the corresponding medical ethical committees (VU Medical Center, Utrecht Medical Center, 
or Leiden University Medical Center). The studies were conducted in accordance with the guidelines and regu-
lations approved by the respective ethical committee and in compliance with the provisions of the declaration of 
Helsinki and Good Clinical Practice. Written informed consent was received from the participants or their legal 
guardians prior to inclusion in the study.
Adult validation sample. 249 healthy adults were included, in a study at VU Amsterdam. Exclusion criteria 
were a history of neurological pathology or current use of medication. 176 subjects (age 19–56 years, M = 24.4 
years, SD = 7 years, 107 females) underwent resting-state EEG recordings with eyes closed, while 73 subjects 
(age 19–47, M = 24 years, SD = 7.8 years, 49 females) had their eyes open. Resting-state EEGs were recorded for 
3–5 minutes using the NetAmps300 amplifier (Electrical Geodesics) and 129-channel HydroCel Geodesic sensor 
nets. The sampling rate was 1000 Hz and the reference electrode was Cz.
Adult zolpidem sample. EEGs recorded from forty medically-screened healthy subjects (age 18–65 years, 3 
females) were made available from the Centre for Human Drug Research, the Netherlands. Subjects had taken 
part in a double-blind randomized study, receiving a capsule orally containing 10 mg zolpidem (20 subjects) 
or placebo (20 subjects). Subsequently, subjects underwent multiple EEG sessions using a bipolar recording 
at PZ-OZ along with a separate channel for recording eye artifacts. Each EEG session included 64 seconds of 
eyes-closed rest. 28 subjects (14 zolpidem) were recorded at 0, 0.33, 1, 1.33, 2, 3, 4, 6, 8, 10 and 12 hours after 
administration of the capsule. 12 subjects (6 zolpidem) were recorded at 0, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12 hours after 
administration. Exclusion criteria for this study were: history or clinical evidence of alcoholism or drug abuse 
within the 3-year period prior to the screening examination, smoking, concomitant treatment with any medica-
tion, or any contraindication or known hypersensitivity to zolpidem.
Children with ASD and typically developing children (TDC) samples. EEGs and symptom-scale baseline meas-
urements were collected from two ongoing studies at the developmental disorder unit in the UMC Utrecht 
(for details see Supplementary Methods). Inclusion criteria for ASD and TDC samples were an age between 
7–16 years, IQ > 55, and ability to comply with study procedures. ASD diagnosis required an expert diagnosis 
1 2Scientific RepoRtS |         (2020) 10:9195  | https://doi.org/10.1038/s41598-020-65500-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
according to the Diagnostic and structural manual of mental disorders (DSM) IV-TR74 or 575 supported by a clin-
ical score on the Autism Diagnostic Observation Schedule 2 (ADOS-2 module 3 or 4, score ≥ 7) or a subclinical 
score on the Social Responsivity Scale (SRS-t-score ≥ 60)76. An abbreviated form of the Wechsler intelligence 
scale for children (WISC)-III was used for IQ estimation. Details regarding the clinical scales are provided in 
Supplementary Methods. Exclusion criteria for the ASD sample were use of psychoactive medication and pres-
ence of other major neurological disease such as previous or current epilepsy diagnoses. The TDC sample was 
recruited from local residents attending non-special education, where a history of behavioral or learning prob-
lems, a diagnosis of any neurodevelopmental condition or any other major health issue was an exclusion criterion.
We recruited a total of 126 subjects that met the inclusion criteria for ASD and 37 TDC. From these, 26 chil-
dren with ASD and 8 TDC were excluded because less than 50% of their recordings were free of transient artifacts 
or no eyes-closed rest EEG had been recorded. Thus, the final included sample consisted of 129 subjects (42 
females): 100 with ASD (7–16 years, M = 10.5 years, SD = 2.3 years, 27 females) and 29 age-matched typically 
developing children (TDC) (7.4–14.4 years, M = 10.3, SD = 1.5 years, 15 females). EEGs were recorded during 
3–5 minutes of eyes-closed rest at the UMC Utrecht using A 64-channel BioSemi EEG system at a sampling rate 
of 2048 Hz and common mode sense (CMS) reference electrode.
Pre-processing and analysis of EEG data. EEG analyses were done using the Neurophysiological Biomarker 
Toolbox (NBT) (http://www.nbtwiki.net/). All recordings were manually cleaned for artifacts, i.e., noisy channels 
were discarded and noisy intervals removed. Final recordings’ length is provided in Supplementary Methods. 
Subsequently, the data were re-referenced to the average reference.
For all samples, spectral power was computed using the Welch method with an 8192-point Blackman win-
dow and a frequency resolution of 0.12 Hz. Relative power was calculated by dividing the absolute power in the 
alpha band with the integrated power in the range 1–45 Hz. The alpha band (8–13 Hz) amplitude envelope was 
extracted for all analyses. The DFA exponent was fit between 2 and 30 seconds for all datasets except for the 
zolpidem sample (see below). Finally, the fE/I was calculated as described above (see ‘estimation for excitation/
inhibition ratio) for windows of 5 seconds with 80% overlap.
Specifically, for the adult zolpidem dataset, recordings were down-sampled from 64768 Hz to 1024 Hz and 
filtered 0.5–70 Hz (4th-order Butterworth filter). The DFA exponent was fit between 2 and 10 seconds due to the 
short length of the signals. The fE/I was averaged for all recordings with a DFA exponent >0.6 (87% of all record-
ings) into four time blocks (0–0.5, 0.5–2, 2–4, 4–6 hours). Only subjects who had at least one recording with DFA 
exponent >0.6 in each of the four time blocks were kept for the analysis, which resulted in the inclusion of 18 of 
the 20 subjects measured in the zolpidem condition, and 14 of the 20 subjects measured in the placebo condition.
Classification of EEG abnormalities. Additionally, the recordings of the children with ASD and TDC were vis-
ually inspected in windows of 10 seconds by a neurologist with training in clinical EEG (neurophysiology and 
epilepsy) (EJM) and scored according to Luders & Noachtar’s classification of EEG abnormalities44. When no 
abnormalities were detected, the EEG was classified as normal.
Statistical analysis. Results are expressed as mean ± SEM. Wilcoxon signed-rank test was used to compare the 
adult zolpidem data at different time points (repeated measures) based on the fE/I value of the Pz-Oz electrode 
(Fig. 3c). For the children samples (ASD and TDC), clinical and demographic comparisons were calculated using 
a t-test (if normality assumptions were met) or Wilcoxon rank-sum test. Wilcoxon rank-sum test was also used 
to compare EEG biomarker values between children with ASD and TDC and within the different ASD EEG 
subgroups (independent measures). Additionally, an ANCOVA test was performed to control for IQ as a covar-
iate. In order to show significance also at the electrode level (64 channels) (white circles on topographic plots in 
Figs. 4 and 5), we used False Discovery Rate (FDR) to correct for multiple testing. For the number of channels 
in our EEG recordings and to show the widespread scalp distribution of the effects in our data, we set q = 0.15 
in the FDR corrections (for details regarding the determination of q see Supplementary Methods). Importantly, 
because of the broad scalp-distribution of the effects, we also report comparisons based on the average value of 
the EEG biomarkers across all 64 electrodes (whole-brain average) and show the individual-subject values in 
Figs. 4 and 5. For these tests, we averaged the value of EEG biomarkers across all electrodes (thus, there is no 
multiple-comparison issue). The significance level was set at p < 0.05. Finally, to determine if the level of core clin-
ical symptoms in ASD had an effect on the fE/I estimates, we used a median split to divide the ASDall group into 
high and low Social Responsiveness Scale (SRS-t) t-scores and compared the groups performing the Wilcoxon 
rank-sum test. The significance level was set at p < 0.05.
Data availability
Due to privacy regulations of human subjects, we cannot provide the EEG files of the subjects included in our study. 
However, we provide the individual demographics and EEG mean biomarker values in Supplementary Table S1. 
Analysis scripts to reproduce the figures and statistics are available at https://figshare.com/projects/Measurement_
of_excitation-inhibition_ratio_in_autism_spectrum_disorder_using_critical_brain_dynamics/80408.
code availability
The code for running the simulations of the CROS model is available at https://figshare.com/projects/
Measurement_of_excitation-inhibition_ratio_in_autism_spectrum_disorder_using_critical_brain_
dynamics/80408. The code for the fE/I algorithm will be publicly available at the time of publication at https://
github.com/rhardstone/fEI.
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